Home / Insights / Five Common IND Application Mistakes That Trigger FDA Clinical Holds Five Common IND Application Mistakes That Trigger FDA Clinical Holds SH Science Habitat Team May 2, 2026 1 min read Based on analysis of public FDA Clinical Hold letters, these are the most frequent deficiencies in first-time IND submissions and how to avoid them.Full article content to be added by the editorial team. Share this article LinkedIn X / Twitter Email